NEW YORK – Thermo Fisher Scientific and Milu Labs said today that they plan to collaborate to develop clinical diagnostic technologies for women's health in China.
Under a memorandum of understanding, the companies plan to explore opportunities to use Thermo Fisher's liquid chromatography-mass spectrometry instrumentation to develop tools to determine the risk for adverse pregnancy outcomes.